glucose, (beta-d)-isomer has been researched along with hematoxylin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Lu, S; Sun, Y; Xu, Y; Ye, X | 1 |
Birnbaum, Y; Chen, H; Nylander, S; Tran, D; Ye, Y | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and hematoxylin
Article | Year |
---|---|
Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors.
Topics: Carrier Proteins; Catalytic Domain; Computer Simulation; Drug Discovery; Enzyme Assays; Glucosides; Hematoxylin; Humans; Indoprofen; Lung Neoplasms; Membrane Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Nalidixic Acid; Protein Kinase Inhibitors; Pyruvate Kinase; Stilbenes; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2016 |
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus.
Topics: Albumins; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Benzhydryl Compounds; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eosine Yellowish-(YS); Glucose; Glucosides; Hematoxylin; Inflammasomes; Insulins; Kidney; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Periodic Acid; Proto-Oncogene Proteins c-akt; Ticagrelor | 2022 |